» Authors » Qingliang Kong

Qingliang Kong

Explore the profile of Qingliang Kong including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 16
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hou Y, Piao H, Tahara Y, Qin S, Wang J, Kong Q, et al.
Eur J Pharm Sci . 2020 Aug; 155:105521. PMID: 32822808
The aim of the current study was to modify the oral absorption of risedronate sodium (RS) using solid-in-oil nanodispersions (SONDs) technology. The oral therapeutic effect of RS is limited in...
2.
Kong Q, Kitaoka M, Wakabayashi R, Tahara Y, Kamiya N, Goto M
Pharmaceutics . 2020 Mar; 12(3). PMID: 32156090
Japanese cedar pollinosis (JCP) is a common affliction caused by an allergic reaction to cedar pollen and is considered a disease of national importance in Japan. Antigen-specific immunotherapy (AIT) is...
3.
Kitaoka M, Xiao W, Kong Q, Tahara Y, Kamiya N, Goto M
Pharmaceutics . 2020 Mar; 12(3). PMID: 32120968
An allergy to cow's milk proteins is the most common food allergy in infants and toddlers. Conventional oral immunotherapy for cow's milk allergies requires hospital admission due to the risk...
4.
Kong Q, Kitaoka M, Tahara Y, Wakabayashi R, Kamiya N, Goto M
Int J Pharm . 2019 Nov; 572:118777. PMID: 31678377
En masse vaccination is a promising strategy for combatting infectious diseases. Intranasal vaccination is a viable route of mass vaccination, and it could be performed easily via needle-free administration. However,...
5.
Kong Q, Higasijima K, Wakabayashi R, Tahara Y, Kitaoka M, Obayashi H, et al.
Pharmaceutics . 2019 Nov; 11(11). PMID: 31671640
Japanese cedar pollinosis is a type I allergic disease and has already become a major public health problem in Japan. Conventional subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) cannot meet...
6.
Kong Q, Kitaoka M, Wakabayashi R, Kamiya N, Goto M
Int J Pharm . 2017 Jul; 529(1-2):401-409. PMID: 28705615
Pollinosis, a typical seasonal allergy, is a serious public health problem. Limited numbers of patients receive curative immunotherapy instead of symptomatic therapy; however, there are still some concerns about the...